内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

痛风基层合理用药指南

2021-06-04 中华全科医师杂志, 2021，20(06)

痛风

痛风是指因血尿酸过高而沉积在关节、组织中造成多种损害的一组疾病，严重者可并发心脑血管疾病、肾功能衰竭，最终可能危及生命，是糖尿病、代谢综合征、血脂异常、慢性肾脏病和脑卒中等疾病发生的独立危险因素。

中文标题：

痛风基层合理用药指南

发布机构：

发布日期：

2021-06-04

简要介绍：

痛风是指因血尿酸过高而沉积在关节、组织中造成多种损害的一组疾病，严重者可并发心脑血管疾病、肾功能衰竭，最终可能危及生命，是糖尿病、代谢综合征、血脂异常、慢性肾脏病和脑卒中等疾病发生的独立危险因素。

相关资料下载：
[AttachmentFileName(sort=1, fileName=痛风基层合理用药指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3bc141c002161033, title=痛风基层合理用药指南, enTitle=, guiderFrom= 中华全科医师杂志, 2021，20(06), authorId=0, author=, summary=痛风是指因血尿酸过高而沉积在关节、组织中造成多种损害的一组疾病，严重者可并发心脑血管疾病、肾功能衰竭，最终可能危及生命，是糖尿病、代谢综合征、血脂异常、慢性肾脏病和脑卒中等疾病发生的独立危险因素。, cover=https://img.medsci.cn/2021824/1629812374394_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>痛风是指因血尿酸过高而沉积在关节、组织中造成多种损害的一组疾病，严重者可并发心脑血管疾病、肾功能衰竭，最终可能危及生命，是糖尿病、代谢综合征、血脂异常、慢性肾脏病和脑卒中等疾病发生的独立危险因素。</p>, tagList=[TagDto(tagId=1530, tagName=痛风)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1530, guiderKeyword=痛风, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5163, appHits=979, showAppHits=0, pcHits=1259, showPcHits=4168, likes=9, shares=82, comments=51, approvalStatus=1, publishedTime=Tue Aug 24 23:49:52 CST 2021, publishedTimeString=2021-06-04, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 24 21:39:53 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 19:39:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=痛风基层合理用药指南.pdf)])
痛风基层合理用药指南.pdf
下载请点击：
评论区 (44)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2124482, encodeId=913c21244829d, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Sat Apr 08 18:59:29 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201919, encodeId=db2c12019196f, content=学习了药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Sat Mar 12 09:43:25 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187890, encodeId=d486118e89006, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:03:01 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187858, encodeId=bfe0118e858cf, content=写得很好，有实用价值！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Jan 24 22:43:22 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186887, encodeId=dc9c118688e4e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31e11781061, createdName=ms7841632680819959, createdTime=Fri Jan 21 17:00:40 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2023-04-08 ms7000001658661498

    可以

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2124482, encodeId=913c21244829d, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Sat Apr 08 18:59:29 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201919, encodeId=db2c12019196f, content=学习了药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Sat Mar 12 09:43:25 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187890, encodeId=d486118e89006, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:03:01 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187858, encodeId=bfe0118e858cf, content=写得很好，有实用价值！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Jan 24 22:43:22 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186887, encodeId=dc9c118688e4e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31e11781061, createdName=ms7841632680819959, createdTime=Fri Jan 21 17:00:40 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-03-12 恒心

    学习了药物

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2124482, encodeId=913c21244829d, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Sat Apr 08 18:59:29 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201919, encodeId=db2c12019196f, content=学习了药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Sat Mar 12 09:43:25 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187890, encodeId=d486118e89006, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:03:01 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187858, encodeId=bfe0118e858cf, content=写得很好，有实用价值！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Jan 24 22:43:22 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186887, encodeId=dc9c118688e4e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31e11781061, createdName=ms7841632680819959, createdTime=Fri Jan 21 17:00:40 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-25 502833265

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2124482, encodeId=913c21244829d, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Sat Apr 08 18:59:29 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201919, encodeId=db2c12019196f, content=学习了药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Sat Mar 12 09:43:25 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187890, encodeId=d486118e89006, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:03:01 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187858, encodeId=bfe0118e858cf, content=写得很好，有实用价值！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Jan 24 22:43:22 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186887, encodeId=dc9c118688e4e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31e11781061, createdName=ms7841632680819959, createdTime=Fri Jan 21 17:00:40 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-24 ms3000000637975859

    写得很好，有实用价值！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2124482, encodeId=913c21244829d, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Sat Apr 08 18:59:29 CST 2023, time=2023-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201919, encodeId=db2c12019196f, content=学习了药物, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Sat Mar 12 09:43:25 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187890, encodeId=d486118e89006, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:03:01 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187858, encodeId=bfe0118e858cf, content=写得很好，有实用价值！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Jan 24 22:43:22 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186887, encodeId=dc9c118688e4e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31e11781061, createdName=ms7841632680819959, createdTime=Fri Jan 21 17:00:40 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-21 ms7841632680819959

    非常好

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

高尿酸血症和痛风病证结合诊疗指南

中国医师协会中西医结合医师分会(DSIM/CMDA,Doctor Society of integrative Medicine，Chinese Medical Doctor Association) · 2021-01-20

痛风及高尿酸血症基层诊疗指南（实践版·2019）

中华医学会(CMA,Chinese Medical Association) · 2020-06-15

2020美国风湿病学会痛风管理指南

美国风湿病学会(ACR,American College of Rheumatology) · 2020-05-11

2018 EULAR循证建议：痛风的诊断（更新版）

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2019-06-05

2018 国际意见书：恰当应用uricosurics和雷西纳德

国外风湿免疫科相关专家小组 · 2018-09-22

2018 台湾多学科共识：痛风及高尿酸血症的管理

台湾多学科工作组（统称） · 2018-01-24

拓展阅读

2011 原发性痛风诊断和治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-06-01

2011 ACR 痛风与高尿酸血症指南

美国风湿病学会(ACR,American College of Rheumatology) · 2011-11-04

2012 ACR 痛风管理指南

美国风湿病学会(ACR,American College of Rheumatology) · 2012-10-01

2013高尿酸血症和痛风治疗中国专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-08-24

2013高尿酸血症和痛风治疗中国专家共识-期刊版

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-11-30

2014 痛风诊断与管理的多国证据推荐意见：源自文献系统回顾整合及风湿专家&quot;3e&quot;方案意见

国外风湿免疫科相关专家小组 · 2014-02-09